Evidence map›Paper›PMID 36613468›Full record

ArticleInternational journal of molecular sciences2022

Predicting the Electronic Absorption Band Shape of Azobenzene Photoswitches.

Ricard Gelabert, Miquel Moreno, José M Lluch

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ricard GelabertDepartament de Química, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.ORCID 0000-0001-6506-5786
Miquel MorenoDepartament de Química, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.ORCID 0000-0002-2784-1307
José M LluchDepartament de Química, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.ORCID 0000-0002-7536-1869

Funding

Ministerio de Ciencia e Innovación (Spain) PID2020-113764GB-I00
6 · The paper itself

Abstract

Simulations based on molecular dynamics coupled to excitation energy calculations were used to generate simulated absorption spectra for a family of halide derivatives of azobenzene, a family of photoswitch molecules with a weak absorption band around 400-600 nm and potential uses in living tissue. This is a case where using the conventional approach in theoretical spectroscopy (estimation of absorption maxima based on the vertical transition from the potential energy minimum on the ground electronic state) does not provide valid results that explain how the observed band shape extends towards the low energy region of the spectrum. The method affords a reasonable description of the main features of the low-energy UV-Vis spectra of these compounds. A bathochromic trend was detected linked to the size of the halide atom. Analysis of the excitation reveals a correlation between the energy of the molecular orbital where excitation starts and the energy of the highest occupied atomic orbital of the free halide atom. This was put to the test with a new brominated compound with good results. The energy level of the highest occupied orbital on the free halide was identified as a key factor that strongly affects the energy gap in the photoswitch. This opens the way for the design of bathochromically shifted variants of the photoswitch with possible applications.

Indexed as

Azo CompoundsElectronicsSpectrum AnalysisazobenzeneAzo Compoundsabsorption band shapeabsorption spectrumazobenzene derivativesmammal optical windowmolecular dynamics simulationsphotoswitch

Identifiers

PMID36613468
PMCPMC9819940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.